Tonal is a Healthtech company based in San Francisco. It has raised $580M in total funding. Latest round: Series E.
Tonal funding overview
Tonal is a Healthtech company based in San Francisco. Tonal has raised $580M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in April 2023. The round record for Tonal runs through 2023; nothing later has been disclosed. Investors on record include Dragoneer Investment Group, SoftBank Vision Fund, General Catalyst, Khosla Ventures, L Catterton, Cobalt Capital and 8 others. 14 distinct backers are named across the disclosed rounds.
Tonal at a glance
Total raised
$580M
Latest round
Series E
Latest round date
April 2023
Industry
Healthtech
Headquarters
San Francisco
Notable investors
Dragoneer Investment Group, SoftBank Vision Fund, General Catalyst, Khosla Ventures, L Catterton, Cobalt Capital, Kindred Ventures, THVC
Frequently asked about Tonal funding
How much has Tonal raised?
Tonal has raised $580M in total disclosed funding across the rounds on record.
Who has invested in Tonal?
Dragoneer Investment Group, SoftBank Vision Fund, General Catalyst, Khosla Ventures, L Catterton, Cobalt Capital are named among the investors backing Tonal.
What was the latest Tonal funding round?
The most recent disclosed round is a Series E, announced in April 2023.
Where is Tonal based?
Tonal is based in San Francisco.
What sector does Tonal operate in?
Tonal is tracked under Healthtech from San Francisco, with $580M in disclosed funding.
When did Tonal last raise?
The last disclosed Tonal round closed in April 2023 at Series E.
Tonal totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in San Francisco below to benchmark round size and investor mix.
